Daniel Lottaz

1.4k total citations
26 papers, 1.0k citations indexed

About

Daniel Lottaz is a scholar working on Cancer Research, Immunology and Allergy and Oncology. According to data from OpenAlex, Daniel Lottaz has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Immunology and Allergy and 9 papers in Oncology. Recurrent topics in Daniel Lottaz's work include Protease and Inhibitor Mechanisms (12 papers), Cell Adhesion Molecules Research (11 papers) and Peptidase Inhibition and Analysis (6 papers). Daniel Lottaz is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Cell Adhesion Molecules Research (11 papers) and Peptidase Inhibition and Analysis (6 papers). Daniel Lottaz collaborates with scholars based in Switzerland, Germany and United States. Daniel Lottaz's co-authors include Erwin E. Sterchi, Walter Stöcker, Dagmar Hahn, Christoph Becker‐Pauly, Stefan Müller, Irene Yiallouros, Judith Bond, A.H. Schutte, Hans‐Willi Krell and Christoph Becker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Daniel Lottaz

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lottaz Switzerland 18 437 384 235 229 134 26 1.0k
Anne Vézina Canada 17 504 1.2× 130 0.3× 219 0.9× 175 0.8× 130 1.0× 18 927
Lydia Santell United States 21 617 1.4× 486 1.3× 123 0.5× 146 0.6× 76 0.6× 31 1.4k
Alpana Ray United States 23 917 2.1× 318 0.8× 244 1.0× 89 0.4× 96 0.7× 62 1.4k
Makiko Kawaguchi Japan 22 559 1.3× 195 0.5× 312 1.3× 77 0.3× 97 0.7× 72 1.3k
Véronique Rigot France 21 604 1.4× 247 0.6× 414 1.8× 253 1.1× 114 0.9× 34 1.3k
E. Ahn United States 22 869 2.0× 262 0.7× 210 0.9× 94 0.4× 69 0.5× 55 1.4k
Kristina Rafidi United States 9 1.1k 2.5× 478 1.2× 361 1.5× 93 0.4× 155 1.2× 9 1.7k
H R Williams United States 11 438 1.0× 336 0.9× 245 1.0× 234 1.0× 77 0.6× 19 1.2k
GA Jamieson United States 13 527 1.2× 153 0.4× 149 0.6× 144 0.6× 149 1.1× 33 1.5k
Cinzia Bagalá Italy 18 629 1.4× 198 0.5× 484 2.1× 60 0.3× 66 0.5× 36 1.3k

Countries citing papers authored by Daniel Lottaz

Since Specialization
Citations

This map shows the geographic impact of Daniel Lottaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lottaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lottaz more than expected).

Fields of papers citing papers by Daniel Lottaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lottaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lottaz. The network helps show where Daniel Lottaz may publish in the future.

Co-authorship network of co-authors of Daniel Lottaz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lottaz. A scholar is included among the top collaborators of Daniel Lottaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lottaz. Daniel Lottaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagler, Michael, Lorenzo Alberio, Hendrik von Tengg‐Kobligk, et al.. (2016). Thromboembolism in patients with congenital afibrinogenaemia. Thrombosis and Haemostasis. 116(10). 722–732. 31 indexed citations
2.
Vazeille, Emilie, Marie-Agnès Bringer, Christophe Chambon, et al.. (2011). Role of Meprins to Protect Ileal Mucosa of Crohn's Disease Patients from Colonization by Adherent-Invasive E. coli. PLoS ONE. 6(6). e21199–e21199. 36 indexed citations
3.
Lottaz, Daniel, Christoph A. Maurer, Agnès Noël, et al.. (2011). Enhanced Activity of Meprin-α, a Pro-Migratory and Pro-Angiogenic Protease, in Colorectal Cancer. PLoS ONE. 6(11). e26450–e26450. 24 indexed citations
4.
Banerjee, Sanjita, D P Jewell, Gail L. Matters, et al.. (2009). MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunology. 2(3). 220–231. 56 indexed citations
5.
Ambort, Daniel, Daniel Lottaz, & Erwin E. Sterchi. (2008). Sample Preparation of Culture Medium from Madin-Darby Canine Kidney Cells. Methods in molecular biology. 425. 113–130. 2 indexed citations
6.
Lottaz, Daniel, Christoph Becker‐Pauly, Walter Stöcker, et al.. (2008). Metalloprotease Meprinβ in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis. PLoS ONE. 3(5). e2278–e2278. 26 indexed citations
7.
Ambort, Daniel, et al.. (2008). A novel 2D‐based approach to the discovery of candidate substrates for the metalloendopeptidase meprin. FEBS Journal. 275(18). 4490–4509. 11 indexed citations
8.
Müller, Eliane J., et al.. (2008). The Metalloprotease Meprinβ Processes E-Cadherin and Weakens Intercellular Adhesion. PLoS ONE. 3(5). e2153–e2153. 61 indexed citations
9.
Lottaz, Daniel, Caroline Buri, Giovanni Monteleone, et al.. (2007). Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease. Biological Chemistry. 388(3). 337–41. 8 indexed citations
10.
Berthier, Céline C., Simone A. Joosten, Cees van Kooten, et al.. (2006). Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets. Kidney International. 69(2). 358–368. 31 indexed citations
11.
Becker‐Pauly, Christoph, Karin Aufenvenne, Vinzenz Oji, et al.. (2006). The α and β Subunits of the Metalloprotease Meprin Are Expressed in Separate Layers of Human Epidermis, Revealing Different Functions in Keratinocyte Proliferation and Differentiation. Journal of Investigative Dermatology. 127(5). 1115–1125. 89 indexed citations
12.
Lottaz, Daniel, Tauseef Ahmad, David A. van Heel, et al.. (2006). Polymorphisms in the MEP1A Gene. Inflammatory Bowel Diseases. 12. S19–S19. 1 indexed citations
13.
Becker, Christoph, Daniel Lottaz, Irene Yiallouros, et al.. (2004). Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochemical Journal. 378(2). 383–389. 141 indexed citations
14.
Hahn, Dagmar, et al.. (2002). Activation of Human Meprin-α in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System. Journal of Biological Chemistry. 277(43). 40650–40658. 45 indexed citations
15.
Lottaz, Daniel, et al.. (2001). Inhibition of ATP-Binding Cassette Transporter Downregulates Interleukin-1β-Mediated Autocrine Activation of Human Dermal Fibroblasts. Journal of Investigative Dermatology. 117(4). 871–876. 10 indexed citations
16.
Bickel, M., et al.. (2001). Soluble interleukin-1 receptor — reverse signaling in innate immunoregulation. Cytokine & Growth Factor Reviews. 12(1). 27–32. 19 indexed citations
17.
Lottaz, Daniel, Dagmar Hahn, Stefan Müller, Christoph Müller, & Erwin E. Sterchi. (1999). Secretion of human meprin from intestinal epithelial cells depends on differential expression of the α and β subunits. European Journal of Biochemistry. 259(1-2). 496–504. 62 indexed citations
18.
20.
Lottaz, Daniel, et al.. (1992). Maturation of human lactase‐phlorizin hydrolase Proteolytic cleavage of precursor occurs after passage through the Golgi complex. FEBS Letters. 313(3). 270–276. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026